Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Management of patients refractory to platelet transfusion.

Sacher RA, Kickler TS, Schiffer CA, Sherman LA, Bracey AW, Shulman IA; College of American Pathologists.Transfusion Medicine Resource Committee.

Arch Pathol Lab Med. 2003 Apr;127(4):409-14.

PMID:
12683867
2.

Refractoriness to platelet transfusion.

Rebulla P.

Curr Opin Hematol. 2002 Nov;9(6):516-20. Review.

PMID:
12394175
3.

The definition of refractoriness to platelet transfusions.

Bishop JF, Matthews JP, Yuen K, McGrath K, Wolf MM, Szer J.

Transfus Med. 1992 Mar;2(1):35-41.

PMID:
1308461
4.

Platelet transfusion refractoriness.

Hod E, Schwartz J.

Br J Haematol. 2008 Jul;142(3):348-60. doi: 10.1111/j.1365-2141.2008.07189.x. Epub 2008 May 28. Review.

PMID:
18510692
5.

Refractory response to platelet transfusion therapy.

Eisenberg S.

J Infus Nurs. 2010 Mar-Apr;33(2):89-97. doi: 10.1097/NAN.0b013e3181cfd392.

PMID:
20228646
6.

Management of patients refractory to platelet transfusion.

Chockalingam P, Sacher RA.

J Infus Nurs. 2007 Jul-Aug;30(4):220-5. Review.

PMID:
17667077
7.

Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens.

Saito S, Ota S, Seshimo H, Yamazaki Y, Nomura S, Ito T, Miki J, Ota M, Fukushima H, Maeda H.

Transfusion. 2002 Mar;42(3):302-8.

PMID:
11961234
8.

Clinical aspects of platelet transfusions.

Murphy MF, Waters AH.

Blood Coagul Fibrinolysis. 1991 Apr;2(2):389-96. Review.

PMID:
1893071
9.

Platelet transfusions: the problem of refractoriness.

Murphy MF, Waters AH.

Blood Rev. 1990 Mar;4(1):16-24. Review.

PMID:
2182145
10.

Diagnosis and management of refractoriness to platelet transfusion.

Schiffer CA.

Blood Rev. 2001 Dec;15(4):175-80. Review.

PMID:
11792118
11.
12.

Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.

Salama A, Kiesewetter H, Kalus U, Movassaghi K, Meyer O.

Thromb Haemost. 2008 Nov;100(5):762-5.

PMID:
18989518
13.

Clinical aspects of platelet transfusion therapy.

Murphy MF.

Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:34-8. Review.

PMID:
7841778
14.

New paradigms in the management of alloimmune refractoriness to platelet transfusions.

Vassallo RR Jr.

Curr Opin Hematol. 2007 Nov;14(6):655-63. Review.

PMID:
17898571
15.
17.
18.

Procoagulant effect of incompatible platelet transfusions in alloimmunized refractory patients.

Mazzara R, Escolar G, Garrido M, Sanz C, Pereira A, Castillo R, Ordinas A.

Vox Sang. 1996;71(2):84-9.

PMID:
8873417
19.

The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.

Benson K, Fields K, Hiemenz J, Zorsky P, Ballester O, Perkins J, Elfenbein G.

Semin Oncol. 1993 Oct;20(5 Suppl 6):102-9. Review.

PMID:
8211211
20.

Algorithm for managing the platelet refractory patient.

Slichter SJ.

J Clin Apher. 1997;12(1):4-9. Review.

PMID:
9097228

Supplemental Content

Support Center